URGN
UroGen Pharma Ltd
3월 13일 4:00 PM ET (한국 3/14 05:00)
$18.44
-0.35 ▼ -1.86%
🌙 3월 13일 4:52 PM ET (한국 3/14 05:52)
$18.44
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -3.21 | Insider Own | 17.98% | Shs Outstand | 0.05B | Perf Week | -9.87% |
| Market Cap | 0.90B | Forward P/E | 20.1 | EPS next Y | 178.5% | Insider Trans | -0.31% | Shs Float | 0.04B | Perf Month | -12.77% |
| Enterprise Value | 0.91B | PEG | - | EPS next Q | -0.5 | Inst Own | 82.3% | Short Float | 20.08% | Perf Quarter | -16.9% |
| Income | -0.15B | P/S | 8.18 | EPS this Y | 63.36% | Inst Trans | 3.98% | Short Ratio | 10.08 | Perf Half Y | -4.21% |
| Sales | 0.11B | P/B | - | EPS next 5Y | - | ROA | -63.14% | Short Interest | 8.02M | Perf YTD | -21.26% |
| Book/sh | -2.18 | P/C | 7.37 | EPS past 3/5Y | 12.81% 11.57% | ROE | - | 52W High | -38.53% ($30.00) | Perf Year | 69.17% |
| Cash/sh | 2.5 | P/FCF | - | Sales past 3/5Y | 19.49% 56.22% | ROIC | -671.51% | 52W Low | 439.18% ($3.42) | Perf 3Y | 95.13% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 0.35% | Gross Margin | 88.66% | Volatility(W/M) | 6.46% 8.05% | Perf 5Y | -5.87% |
| Dividend TTM | - | EV/Sales | 8.25 | Sales Y/Y TTM | 21.45% | Oper. Margin | -113.73% | ATR (14) | 1.5 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.65 | EPS Q/Q | 31.63% | Profit Margin | -139.81% | RSI (14) | 39.23 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.01 | Sales Q/Q | 54.03% | SMA20 | -8.84% ($20.23) | Beta | 1.41 | Target Price | $35.62 |
| Payout | - | Debt/Eq | - | Earnings | 3000000 | SMA50 | -10.59% ($20.62) | Rel Volume | 0.99 | Prev Close | $18.79 |
| Employees | 291 | LT Debt/Eq | - | EPS/Sales Surpr. | -7.48% -5.2% | SMA200 | -2.14% ($18.84) | Avg Volume(3M) | 0.80M | Price | $18.44 |
| IPO | 2017/5/4 | Option/Short | Yes/Yes | Trades | 5833 | Volume | 786,244 | Change | -1.86% |
뉴스 로딩 중...